These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36531293)

  • 21. Caregiver and community perceptions and experiences participating in an infant malaria prevention trial of PfSPZ Vaccine administered by direct venous inoculation: a qualitative study in Siaya County, western Kenya.
    Achieng F; Rosen JG; Cherop RY; Kariuki S; Hoffman SL; Seder R; Oneko M; Steinhardt LC
    Malar J; 2020 Jun; 19(1):226. PubMed ID: 32580719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparing for human papillomavirus vaccine introduction in Kenya: implications from focus-group and interview discussions with caregivers and opinion leaders in Western Kenya.
    Friedman AL; Oruko KO; Habel MA; Ford J; Kinsey J; Odhiambo F; Phillips-Howard PA; Wang SA; Collins T; Laserson KF; Dunne EF
    BMC Public Health; 2014 Aug; 14():855. PubMed ID: 25128911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Why vaccines matter: understanding the broader health, economic, and child development benefits of routine vaccination.
    Nandi A; Shet A
    Hum Vaccin Immunother; 2020 Aug; 16(8):1900-1904. PubMed ID: 31977283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting vaccination demand in Indonesia: a secondary analysis and multimethods national assessment.
    Jusril H; Rachmi CN; Amin MR; Dynes M; Sitohang V; Untung ASB; Damayanti R; Ariawan I; Pronyk PM
    BMJ Open; 2022 Aug; 12(8):e058570. PubMed ID: 35953251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding determinants of vaccine hesitancy and acceptance in India: A qualitative study of government officials and civil society stakeholders.
    Erchick DJ; Gupta M; Blunt M; Bansal A; Sauer M; Gerste A; Holroyd TA; Wahl B; Santosham M; Limaye RJ
    PLoS One; 2022; 17(6):e0269606. PubMed ID: 35679276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of access to immunization information on vaccine acceptance in three countries.
    Handy LK; Maroudi S; Powell M; Nfila B; Moser C; Japa I; Monyatsi N; Tzortzi E; Kouzeli I; Luberti A; Theodoridou M; Offit P; Steenhoff A; Shea JA; Feemster KA
    PLoS One; 2017; 12(8):e0180759. PubMed ID: 28771485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in vaccine investment in middle income countries.
    Onishchenko K; Hill S; Wasserman M; Jones C; Moffatt M; Ruff L; Pugh SJ
    Hum Vaccin Immunother; 2019; 15(10):2378-2385. PubMed ID: 30843757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is 'confidence' and what could affect it?: A qualitative study of mothers who are hesitant about vaccines.
    Mendel-Van Alstyne JA; Nowak GJ; Aikin AL
    Vaccine; 2018 Oct; 36(44):6464-6472. PubMed ID: 28899629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementing the communication for development strategy to improve knowledge and coverage of measles vaccination in western Chinese immunization programs: a before-and-after evaluation.
    Lu M; Chu YZ; Yu WZ; Scherpbier R; Zhou YQ; Zhu X; Su QR; Duan MJ; Zhang X; Cui FQ; Wang HQ; Zhou YB; Jiang QW
    Infect Dis Poverty; 2017 Apr; 6(1):47. PubMed ID: 28434402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccine hesitancy among mobile pastoralists in Chad: a qualitative study.
    Abakar MF; Seli D; Lechthaler F; Schelling E; Tran N; Zinsstag J; Muñoz DC
    Int J Equity Health; 2018 Nov; 17(1):167. PubMed ID: 30428876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches.
    Watts E; Sim SY; Constenla D; Sriudomporn S; Brenzel L; Patenaude B
    Value Health; 2021 Jan; 24(1):78-85. PubMed ID: 33431157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing barriers to access and equity for COVID-19 vaccination in the US.
    Kuehn M; LaMori J; DeMartino JK; Mesa-Frias M; Doran J; Korrapati L; Bhojwani R; Lefebvre P; Kirson N
    BMC Public Health; 2022 Dec; 22(1):2263. PubMed ID: 36463172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination information, motivations, and barriers in the context of meningococcal serogroup A conjugate vaccine introduction: A qualitative assessment among caregivers in Burkina Faso, 2018.
    Aksnes BN; Walldorf JA; Nkwenkeu SF; Zoma RL; Mirza I; Tarbangdo F; Fall S; Hien S; Ky C; Kambou L; Diallo AO; Aké FH; Hatcher C; Patel JC; Novak RT; Hyde TB; Medah I; Soeters HM; Jalloh MF
    Vaccine; 2021 Oct; 39(43):6370-6377. PubMed ID: 34579975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using immunisation caregiver journey interviews to understand and optimise vaccination uptake: lessons from Sierra Leone.
    Jalloh MF; Hickler B; Parmley LE; Sutton R; Kulkarni S; Mansaray A; Eleeza O; Patel P; Wilhelm E; Conklin L; Akinjeji A; Toure M; Wolff B; Prybylski D; Wallace AS; Lahuerta M
    BMJ Glob Health; 2021 May; 6(5):. PubMed ID: 34045184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gaps in measles vaccination coverage in Kasese district, Western Uganda: results of a qualitative evaluation.
    Walekhwa AW; Musoke D; Nalugya A; Biribawa C; Nsereko G; Wafula ST; Nakazibwe B; Nantongo M; Odera DA; Chiara A; Boyce RM; Mulogo EM
    BMC Infect Dis; 2022 Jul; 22(1):589. PubMed ID: 35787247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts.
    Postma M; Biundo E; Chicoye A; Devlin N; Mark Doherty T; Garcia-Ruiz AJ; Jaros P; Sheikh S; Toumi M; Wasem J; Beck E; Salisbury D; Nolan T
    Vaccine; 2022 Jun; 40(30):3999-4007. PubMed ID: 35597688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of interventions that apply new media to improve vaccine uptake and vaccine coverage.
    Odone A; Ferrari A; Spagnoli F; Visciarelli S; Shefer A; Pasquarella C; Signorelli C
    Hum Vaccin Immunother; 2015; 11(1):72-82. PubMed ID: 25483518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors affecting immunization coverage levels in a district of India.
    Balraj V; Mukundan S; Samuel R; John TJ
    Int J Epidemiol; 1993 Dec; 22(6):1146-53. PubMed ID: 8144298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding vaccine acceptance and demand-and ways to increase them.
    Habersaat KB; Jackson C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jan; 63(1):32-39. PubMed ID: 31802154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low vaccination in rural Sindh, Pakistan: A case of refusal, ignorance or access?
    Jamal D; Zaidi S; Husain S; Orr DW; Riaz A; Farrukhi AA; Najmi R
    Vaccine; 2020 Jun; 38(30):4747-4754. PubMed ID: 32467011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.